Novo Nordisk said it will stop selling Wegovy on Hims & Hers, claiming the telehealth company sold knockoff versions of the ...

San Francisco telehealth company Hims & Hers saw its stock plunge more than 30% earlier this week after a partnership with ...

Novo Nordisk A/S (NYSE:NVO) is one of the 12 stocks that will make you rich in 10 years. On June 23, the company discontinued ...

Novo Nordisk said Hims & Hers has "failed to adhere to the law which prohibits mass sales of compounded drugs" under the ...

STORY: Novo Nordisk is to collaborate with WeightWatchers to sell its blockbuster weight-loss drug Wegovy.Under the deal to ...

The stock's market-beating momentum has come crashing to a halt, following shocking allegations from one of the world's largest pharmaceutical companies.

While some compounding pharmacies have stopped making alternatives to Wegovy and Zepbound since shortages were declared over, ...

Mounting demand for Novo Nordisk-made Ozempic and Wegovy has fueled a rise of illegal sales of the weight-loss drugs in Denmark, where the pharma giant is based, the Danish Medicines Agency reported.

Wegovy is approved to treat chronic weight management, but it has far more potential in the future. Another indication, for reducing the risk of cardiovascular disease, could be coming in 2024. In ...

Wegovy's coverage could soon be much broader. In 2021, the Food and Drug Administration (FDA) approved Wegovy to help treat people with chronic weight management in adults with obesity or who are ...

The count-down's on for New Zealand chemist sales of weight-loss drug Wegovy. A pharmacist has told our newsroom the ...

Sales of Ozempic are booming. Maker Novo Nordisk on Friday raised its sales and profit outlook for the year because of higher-than-expected U.S. prescription volumes for Ozempic, the diabetes drug ...